Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Pratima Deshpande"'
Autor:
Dhanalakshmi Sivanandhan, Santhosh Viswakarma, Rashmi Rekha Devi, Ramchandraiah Gosu, Tabassum Sahareen, Chandregowda Venkateshappa, Chandru Gajendran, Pratima Deshpande, Muralidhar Reddy, Sundarajan kannan, Prashanthi Daram, Pendyala Satya Kishore, Amir Siddiqui, Mohammed Zainuddin, Naveen Sadhu M, Sridharan Rajagopal, Rudresh G
Publikováno v:
Cancer Research. 81:1630-1630
Introduction: The PD-1/PD-L1 molecular pathway is one of the primary mechanisms of immune evasion deployed by cancer cells. Induction of PD-L1 expression on cancer cells is associated with inhibition of immune responses against cancer, thus favouring
Publikováno v:
2017 International Conference on Energy, Communication, Data Analytics and Soft Computing (ICECDS).
Security in Embedded systems has become an important constraint in modern days. There are different cryptographic algorithms developed for providing data security. Among these Diffie-Hellman is the basic one. Diffie-Hellman Key Exchange method of cry
Autor:
Sergey Pryshchep, Jörg J. Goronzy, Pratima Deshpande, Ines Colmegna, Vladimir M. Liarski, Karnail Singh, Cornelia M. Weyand
Publikováno v:
The Journal of Immunology. 183:8258-8267
Immune responses to citrullinated neoantigens and clinical efficacy of costimulation blockade indicate a general defect in maintaining T cell tolerance in rheumatoid arthritis (RA). To examine whether TCR threshold calibration contributes to disease
Autor:
Pratima Deshpande, Ravi K. Babu, Anu-Maarit Moilanen, Pekka Kallio, Mahaboobi Jaleel, Chandrasekhar Abbineni, Susanta Samajdar, Prashant Yallappa Vadnal, Murali Ramachandra
Publikováno v:
Cancer Research. 77:LB-113
Background: ODM-207 is a potent and selective BET inhibitor that is structurally unrelated to the benzodiazepine-based inhibitors including JQ1, I-BET762, and OTX015. Phase I clinical trials have now been initiated with this agent based on its potent
Autor:
Mary M. Cavanagh, Karnail Singh, Sabine Le Saux, Pratima Deshpande, Cornelia M. Weyand, Jörg J. Goronzy
Regulation of the ERK pathway is intimately involved in determining whether TCR stimulation is productive or induces anergy. T cells from patients with rheumatoid arthritis (RA) have increased ERK responsiveness, which may be relevant for disease pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f829d2901699abae175f226ca9e9a66
https://europepmc.org/articles/PMC3574821/
https://europepmc.org/articles/PMC3574821/
Autor:
Mingcan Yu, Guangjin Li, Karnail Singh, Sergey Pryshchep, Mary M. Cavanagh, Pratima Deshpande, Cornelia M. Weyand, Jörg J. Goronzy
Publikováno v:
Proceedings of the National Academy of Sciences. 109
Autoantibodies to common autoantigens and neoantigens, such as IgG Fc and citrullinated peptides, are immunological hallmarks of rheumatoid arthritis (RA). We examined whether a failure in maintaining tolerance is mediated by defects in T-cell recept
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 178(11)
CD11c+ dendritic cells (DCs) are a prominent component of CNS infiltrates in mice with experimental autoimmune encephalomyelitis. However, their role in immunopathogenesis is controversial. In this study, we report that they originate from peripheral
Publikováno v:
Journal of neuroimmunology. 173(1-2)
Experimental autoimmune encephalomyelitis (EAE) is an inflammatory demyelinating disease of the central nervous system. IL-12p40 monokines play a critical role in the generation of EAE-inducing CD4+T cells. Here we show that IL-12 directly upregulate
Publikováno v:
The Journal of Immunology. 186:101.16-101.16
In animal models, lymphopenia and the associated function of homeostatic cytokines (HC) set the stage for autoimmunity. This model is relevant for rheumatoid arthritis (RA) which has defects in T cell homeostasis due to a failure in DNA repair and wh
Publikováno v:
The Journal of Immunology. 182:49.8-49.8
Immune responses to citrullinated neoantigens indicate a tolerance defect in rheumatoid arthritis (RA). We examined the hypothesis that abnormal TCR signaling in RA T cells lowers the activation threshold. T cells from 33 seropositive RA patients and